LESODEC

We are service providers in a DIGITAL GLOBAL HEALTH SPACE

Healthcare Data Management Tools

Lesodec Connect
LMDPC
HFA Application

PRODUCTS AND SERVICES

Public Health Systems & softwares
Healthcare Consultancy Expertise
Research and Development
Clinical Research
Drug Regulatory Affairs
Healthcare Market Access Services
Healthcare Data and Media

Services

Our services are designed to enable efficient public healthcare provision to our stakeholders such as; public health organisations, governmental, non-governmental organisations NGOs and International bodies.

PUBLIC HEALTH TECHNOLOGY

We design and develop public health systems that enable efficient data handling and manipulation, thereby facilitating strategic decision making.

HEALTHCARE MARKET ACCESS

We also bolster pharmacovigilance activities on behalf of pharmaceutical companies, national bodies and other interested stakeholders.

DRUGS REGULATORY AFFAIRS

Assess the legal aspects leading to registration of new drugs with regulatory authorities, preparation of dossiers and engagement with other relevant regulatory authorities.

RESEARCH & DEVELOPMENT

LESODEC seeks to use R&D to help clients ensure that drugs and general health products are not only safe and effective, but are also affordable, acceptable by international health standards, and accessible to those who need them most. The firm will also engage with Research and Development to prevent the development or recurrences of diseases.

CLINICAL RESEARCH

We participate in the clinical investigations of new and better ways to detect, diagnose, treat, and prevent diseases. We work in coordination with other international clinical research organizations and pharmaceutical companies to conduct clinical trials and pharmacovigilance services for newly designed drugs.

HEALTHCARE DATA AND MEDIA

We perform data modelling analysis and data packaging for media publication.

STAKEHOLDERS

Portfolio

Our mandate is to offer effective consultancy expertise in the area of research and development, general public health issues, biopharmaceutical services, drug discovery, regulatory affairs and post market surveillance.